human beta glucosidase biosimilar (PanGen Biotech)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Namehuman beta glucosidase biosimilar (PanGen Biotech)

Drug Alias NameN/A

ClassificationBiologics > BiosimilarBiologics > Protein drugs > Enzyme > Recombinant enzymeBiologics > Protein drugs > Recombinant protein > Recombinant enzyme

Mechanisms of Actionβ-glucosidase stimulants

Targetsβ-glucosidase

Therapy Area/IndicationsN/A

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySouth Korea

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesPangen Biotech

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesPangen Biotech

Active IndicationsN/A

Inactive IndicationsN/A

Other Information

ATC CodeN/A